{"title":"A rapid LC-MS/MS method for the simultaneous quantification of 10 key folate cycle intermediates in human plasma.","authors":"Sihan Wang, Xiaona Li, Yuanyuan Zhang, Xianhua Zhang, Xin Xiong, Changqing Yang, Libo Zhao","doi":"10.1016/j.jpba.2025.117178","DOIUrl":null,"url":null,"abstract":"<p><p>The folate cycle is essential for regulating metabolic processes. Simultaneous measurement of folate cycle intermediates is crucial for understanding metabolic disruptions in hematopoietic, nervous, renal and cardiovascular diseases. Currently, liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods for folate cycle metabolites showed poor retention for highly polar compounds in reversed-phase separations with long analytical run time (30 min). Herein, we developed a novel LC-MS/MS method using hydrophilic interaction liquid chromatography (HILIC) mode for simultaneous measurement of 10 key folate cycle metabolites in human plasma, including 5 folate intermediates, 4 related amino acids, and a cofactor (VB<sub>12</sub>), with enhanced chromatographic retention and reduced analysis time (8.5 min) without derivatization. Through further method validation, all analytes demonstrated acceptable linearity (R² > 0.989), precision (intra-day precision: 1.3-11.3 %; inter-day precision: 3.4-14.6 %), recovery (89.5-113.8 %) and reasonable matrix effect (81.6-115.8 %). The results presented that all intermediates were stable for 5 h at 5°C (autosampler), 12 h at -40°C and 24 h at -80°C. Moreover, the method was successfully applied in clinical plasma from critically ill patients, revealing distinct metabolic perturbations in acute kidney injury (AKI) inpatients compared with non-AKI controls (NAKI). Levels of 5-MTHF and Gly were significantly elevated in the AKI group. Correlation analysis revealed that SCr levels were positively correlated with both 5-MTHF (r = 0.26, p = 0.04) and hCys (r = 0.27, p = 0.04) concentrations. The study is promising to evaluate folate nutritional status to mitigate the risks of folate-related diseases, such as megaloblastic anemia and neural tube defects.</p>","PeriodicalId":16685,"journal":{"name":"Journal of pharmaceutical and biomedical analysis","volume":"268 ","pages":"117178"},"PeriodicalIF":3.1000,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pharmaceutical and biomedical analysis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jpba.2025.117178","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
引用次数: 0
Abstract
The folate cycle is essential for regulating metabolic processes. Simultaneous measurement of folate cycle intermediates is crucial for understanding metabolic disruptions in hematopoietic, nervous, renal and cardiovascular diseases. Currently, liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods for folate cycle metabolites showed poor retention for highly polar compounds in reversed-phase separations with long analytical run time (30 min). Herein, we developed a novel LC-MS/MS method using hydrophilic interaction liquid chromatography (HILIC) mode for simultaneous measurement of 10 key folate cycle metabolites in human plasma, including 5 folate intermediates, 4 related amino acids, and a cofactor (VB12), with enhanced chromatographic retention and reduced analysis time (8.5 min) without derivatization. Through further method validation, all analytes demonstrated acceptable linearity (R² > 0.989), precision (intra-day precision: 1.3-11.3 %; inter-day precision: 3.4-14.6 %), recovery (89.5-113.8 %) and reasonable matrix effect (81.6-115.8 %). The results presented that all intermediates were stable for 5 h at 5°C (autosampler), 12 h at -40°C and 24 h at -80°C. Moreover, the method was successfully applied in clinical plasma from critically ill patients, revealing distinct metabolic perturbations in acute kidney injury (AKI) inpatients compared with non-AKI controls (NAKI). Levels of 5-MTHF and Gly were significantly elevated in the AKI group. Correlation analysis revealed that SCr levels were positively correlated with both 5-MTHF (r = 0.26, p = 0.04) and hCys (r = 0.27, p = 0.04) concentrations. The study is promising to evaluate folate nutritional status to mitigate the risks of folate-related diseases, such as megaloblastic anemia and neural tube defects.
期刊介绍:
This journal is an international medium directed towards the needs of academic, clinical, government and industrial analysis by publishing original research reports and critical reviews on pharmaceutical and biomedical analysis. It covers the interdisciplinary aspects of analysis in the pharmaceutical, biomedical and clinical sciences, including developments in analytical methodology, instrumentation, computation and interpretation. Submissions on novel applications focusing on drug purity and stability studies, pharmacokinetics, therapeutic monitoring, metabolic profiling; drug-related aspects of analytical biochemistry and forensic toxicology; quality assurance in the pharmaceutical industry are also welcome.
Studies from areas of well established and poorly selective methods, such as UV-VIS spectrophotometry (including derivative and multi-wavelength measurements), basic electroanalytical (potentiometric, polarographic and voltammetric) methods, fluorimetry, flow-injection analysis, etc. are accepted for publication in exceptional cases only, if a unique and substantial advantage over presently known systems is demonstrated. The same applies to the assay of simple drug formulations by any kind of methods and the determination of drugs in biological samples based merely on spiked samples. Drug purity/stability studies should contain information on the structure elucidation of the impurities/degradants.